Business Wire

Lyophilized Drugs, Reconstitution Devices and Injection Market Report 2024 - The Importance of Technology and Regulatory Factors on Commercialization and Market Access ...

DUBLIN--(BUSINESS WIRE)--The "Lyophilized Drugs, Reconstitution Devices and Injection Markets: Products, Markets, Therapeutics, Strategies & Forecasts" report has been added to ...
TMCnet

Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution

BRIDGEWATER, N.J., June 04, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced that the U.S. Food and Drug Administration (FDA) has ...
FiercePharma

Nutropin AQ growth hormone injection device, ViroPharma introduces new reconstitution system for Cinryze;

> Genentech has introduced a new pre-filled, multi-dose injection device for the administration of Nutropin AQ, a recombinant growth hormone for patients with growth disorders. "NuSpin" is the first ...
Nature

Effects of MSC co-injection on the reconstitution of aplastic anemia patient following hematopoietic stem cell transplantation

You have full access to this article via your institution. MSC were isolated from the patient's (recipient) BM samples collected pre- and post-fourth transplant and characterized morphologically and ...
InvestorsHub on MSN

Amneal Pharmaceuticals advances after securing FDA clearance for cancer treatment (AMRX)

Amneal Pharmaceuticals Inc. Class A (NASDAQ:AMRX) traded higher in premarket activity on Thursday after receiving U.S. Food ...

$17.5+ Bn Dual Chamber Devices (Syringe) Market Trends and Forecasts, 2026-2040: Next-generation Drug Delivery Solutions to Create Substantial Growth Opportunities for ...

The global dual chamber devices market presents growth opportunities driven by the rising demand for patient-friendly, accurate drug delivery systems, particularly in biologics. Advancements in ...